Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126819991 | 12681999 | 1 | I | 2001 | 20160812 | 20160824 | 20160824 | EXP | US-BAXALTA-2016BLT005924 | BAXALTA | 59.00 | YR | F | Y | 0.00000 | 20160824 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126819991 | 12681999 | 1 | PS | GAMMAGARD LIQUID | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | 40 G, UNK | U | 125105 | 40 | G | SOLUTION FOR INFUSION | ||||||
126819991 | 12681999 | 2 | SS | IMMUNOGLOBULIN, NORMAL HUMAN | HUMAN IMMUNOGLOBULIN G | 1 | Unknown | U | 0 | POWDER AND SOLVENT FOR SOLUTION FOR INFUSION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126819991 | 12681999 | 1 | Primary immunodeficiency syndrome |
126819991 | 12681999 | 2 | Primary immunodeficiency syndrome |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126819991 | 12681999 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126819991 | 12681999 | Coeliac disease | |
126819991 | 12681999 | Fibromyalgia | |
126819991 | 12681999 | Infectious mononucleosis | |
126819991 | 12681999 | Pain | |
126819991 | 12681999 | Procedural complication | |
126819991 | 12681999 | Staphylococcal infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |